HK1222810A1 - 治疗开角型青光眼和高眼压症的药物递送系统和方法 - Google Patents

治疗开角型青光眼和高眼压症的药物递送系统和方法 Download PDF

Info

Publication number
HK1222810A1
HK1222810A1 HK16111148.0A HK16111148A HK1222810A1 HK 1222810 A1 HK1222810 A1 HK 1222810A1 HK 16111148 A HK16111148 A HK 16111148A HK 1222810 A1 HK1222810 A1 HK 1222810A1
Authority
HK
Hong Kong
Prior art keywords
latanoprost
eye
implant
iop
lacrimal
Prior art date
Application number
HK16111148.0A
Other languages
English (en)
Chinese (zh)
Inventor
潘迪克．烏特克赫德
潘迪克．乌特克赫德
蘇珊娜．卡登
苏珊娜．卡登
郝勇
Original Assignee
麦提疗法有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 麦提疗法有限公司 filed Critical 麦提疗法有限公司
Publication of HK1222810A1 publication Critical patent/HK1222810A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Prostheses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
HK16111148.0A 2012-05-03 2013-02-27 治疗开角型青光眼和高眼压症的药物递送系统和方法 HK1222810A1 (zh)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US201261642287P 2012-05-03 2012-05-03
US61/642,287 2012-05-03
US201261644401P 2012-05-08 2012-05-08
US201261644397P 2012-05-08 2012-05-08
US61/644,397 2012-05-08
US61/644,401 2012-05-08
US201261659921P 2012-06-14 2012-06-14
US61/659,921 2012-06-14
US201261680641P 2012-08-07 2012-08-07
US61/680,641 2012-08-07
US201261717615P 2012-10-23 2012-10-23
US61/717,615 2012-10-23
PCT/IB2013/000694 WO2013164671A1 (en) 2012-05-03 2013-02-27 Drug delivery system and methods of treating open angle glaucoma and ocular hypertension

Publications (1)

Publication Number Publication Date
HK1222810A1 true HK1222810A1 (zh) 2017-07-14

Family

ID=49514247

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16111148.0A HK1222810A1 (zh) 2012-05-03 2013-02-27 治疗开角型青光眼和高眼压症的药物递送系统和方法

Country Status (7)

Country Link
EP (1) EP2844224B1 (enExample)
JP (1) JP6213560B2 (enExample)
CN (1) CN105473130A (enExample)
CA (1) CA2872338C (enExample)
HK (1) HK1222810A1 (enExample)
IN (1) IN2014DN09713A (enExample)
WO (1) WO2013164671A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG187770A1 (en) 2010-08-12 2013-03-28 Univ Nanyang Tech A liposomal formulation for ocular drug delivery
US9956195B2 (en) 2014-01-07 2018-05-01 Nanyang Technological University Stable liposomal formulations for ocular drug delivery
GB201714392D0 (en) * 2017-09-07 2017-10-25 Marsteller Laurence Methods and devices for treating glaucoma

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3321108A (en) 1965-11-26 1967-05-23 William E Bowe Printing ink dispenser
US3681608A (en) 1971-03-17 1972-08-01 Us Navy Laser beam receiver having a high signal to noise ratio
US4281654A (en) 1980-04-07 1981-08-04 Alza Corporation Drug delivery system for controlled ocular therapy
US4952581A (en) 1987-04-03 1990-08-28 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
US4936008A (en) 1988-05-09 1990-06-26 Teledyne Mec Laser striping method for assembling TWT
US4934708A (en) 1988-05-20 1990-06-19 Kolkind Gerald L Family quiz board game
US5296504A (en) 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5259508A (en) 1992-08-27 1993-11-09 Beckerman Stephen M Protective shipping package
ES2105333T3 (es) 1992-10-13 1997-10-16 Alcon Lab Inc Combinaciones de prostaglandinas y derivados de clonidina para el tratamiento del glaucoma.
US6622308B1 (en) 1999-03-23 2003-09-16 Scientific-Atlanta, Inc. Automatic digital television (DTV) bypass for a CATV converter using a CATV tuner
US6534693B2 (en) 2000-11-06 2003-03-18 Afmedica, Inc. Surgically implanted devices having reduced scar tissue formation
US7300364B2 (en) 2004-02-06 2007-11-27 Acushnet Company Multi-layer golf ball having velocity gradient from faster center to slower cover
EP1603485A4 (en) 2003-02-26 2011-03-30 Medivas Llc BIOACTIVE STENTS AND METHOD OF USE THEREOF
JP4104137B2 (ja) * 2003-05-30 2008-06-18 有限会社エム・エル・シー 涙点プラグ
US7662864B2 (en) 2003-06-04 2010-02-16 Rutgers, The State University Of New Jersey Solution polymerization processes to prepare a polymer that degrades to release a physiologically active agent
US20050129731A1 (en) 2003-11-03 2005-06-16 Roland Horres Biocompatible, biostable coating of medical surfaces
KR100850133B1 (ko) 2004-01-05 2008-08-04 니콕스 에스. 에이. 프로스타글란딘 나이트로옥시 유도체
US20050232972A1 (en) * 2004-04-15 2005-10-20 Steven Odrich Drug delivery via punctal plug
CN101052435B (zh) 2004-07-02 2010-12-08 Qlt塞子传递公司 治疗介质递送装置
ES2640458T3 (es) 2006-03-31 2017-11-03 Mati Therapeutics Inc. Implantes del sistema de drenaje nasolagrimal para terapia medicamentosa
AU2007339929A1 (en) * 2006-12-26 2008-07-10 Qlt Inc. Drug delivery implants for inhibition of optical defects
UY30883A1 (es) 2007-01-31 2008-05-31 Alcon Res Tapones punctales y metodos de liberacion de agentes terapeuticos
NZ598483A (en) 2007-09-07 2013-08-30 Quadra Logic Tech Inc Drug cores for sustained release of therapeutic agents
CA2698508C (en) 2007-09-07 2017-06-06 Alan R. Rapacki Lacrimal implants and related methods
KR20100058620A (ko) 2007-09-07 2010-06-03 큐엘티 플러그 딜리버리, 인코포레이티드 눈물 임플랜트용 삽입 및 적출 기구
EP3372205A1 (en) 2007-09-07 2018-09-12 Mati Therapeutics Inc. Lacrimal implant detection
BRPI0912182A2 (pt) * 2008-05-09 2015-10-06 Qlt Plug Delivery Inc distribuição de liberação prolongada de agentes ativos pára tratar glaucoma e hipertensão ocular
SG173069A1 (en) 2009-01-23 2011-08-29 Quadra Logic Tech Inc Sustained released delivery of one or more agents
KR20110132369A (ko) * 2009-02-23 2011-12-07 큐엘티 인코포레이티드 눈물 임플란트 및 관련 방법
CA2781629A1 (en) 2009-11-27 2011-06-03 Sascha K. Zarins Lacrimal implants including split and insertable drug core

Also Published As

Publication number Publication date
JP2015520628A (ja) 2015-07-23
EP2844224A4 (en) 2016-02-24
WO2013164671A1 (en) 2013-11-07
CA2872338A1 (en) 2013-11-07
IN2014DN09713A (enExample) 2015-07-31
EP2844224A1 (en) 2015-03-11
CN105473130A (zh) 2016-04-06
EP2844224B1 (en) 2018-04-11
CA2872338C (en) 2021-09-14
JP6213560B2 (ja) 2017-10-18

Similar Documents

Publication Publication Date Title
US10632012B2 (en) Sustained release delivery of active agents to treat glaucoma and ocular hypertension
EP2389221B1 (en) Sustained released delivery of one or more agents
CA2722971C (en) Sustained release delivery of active agents to treat glaucoma and ocular hypertension
US20090318549A1 (en) Combination treatment of glaucoma
US9974685B2 (en) Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
JP6213560B2 (ja) 薬剤送達システムならびに開放隅角緑内障および高眼圧症を治療する方法
HK1158951A (en) Sustained release delivery of active agents to treat glaucoma and ocular hypertension
HK1162151B (en) Sustained released delivery of one or more agents
HK1156835A (zh) 青光眼的聯合治療